Clinical Management of Attention Deficit Hyperactivity Disorder (ADHD)
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".
Deadline for manuscript submissions: 15 May 2026 | Viewed by 19
Special Issue Editor
Interests: neurodevelopmemntal disorders; addiction disorders; psychopharmacology; psychopathology
Special Issue Information
Dear Colleagues,
This Special Issue highlights the need to further explore the clinical and psychopathological aspects of adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD) undergoing pharmacological treatment with opioid agonists. Currently, there are significant challenges in the pharmacological management and clinical care of these patients within Italian Addiction Services. Moreover, individuals with ADHD who access addiction services are often not properly diagnosed and, as a result, do not receive appropriate pharmacological treatment.
The aim of this work is to improve clinical practice and enhance current knowledge regarding adult ADHD patients receiving specific opioid dependence therapies with racemic methadone, who subsequently transition to levomethadone.
Dr. Alessandro Pallucchini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ADHD
- addiction
- neurodevelopmental disorders
- levomethadone
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
